Marsh Rebecca M, Silosky Michael S
Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, 80045, USA.
Med Phys. 2017 Apr;44(4):1514-1524. doi: 10.1002/mp.12137. Epub 2017 Mar 17.
Review of dose metrics as part of the routine evaluation of CT protocols has become commonplace and is required by the Joint Commission and the American College of Radiology for accreditation. Most CT quality assurance programs include a review of CTDI and/or SSDE, both of which are affected by changes in mAs and kV. mAs, and sometimes kV, are largely determined by the Tube Current Modulation (TCM) functions of the scanner. TCM, in turn, relies on localizer scans to provide an accurate estimate of patient size. When patient size estimates are inaccurate, TCM and SSDE calculations are affected, leading to errors in both. It is important that those who are involved in reviewing CT dose indices recognize these effects to properly direct quality improvement initiatives.
An anthropomophic phantom was scanned on four clinical CT scanners using AP and PA localizers and the institution's routine abdomen protocol. Scans were repeated with the phantom at various heights relative to scanner isocenter. For each height, the projected phantom width, as shown by the localizer scans, was measured and normalized by the width of the helical scan. After each localizer scan, the TCM algorithm determined the mAs to be used for the helical scan. The scanner-reported average CTDI was recorded for each helical scan, and the SSDE was calculated from the projected phantom size and the scanner-reported CTDI at each phantom height. Last, the phantom was augmented with a lipid-gel bolus material to simulate different body mass distributions and investigate the effect of differing body habitus on projected phantom size. The results were considered in the context of optimizing dose in CT imaging, with particular attention paid to the effect on dose to breast tissue.
Vertical mis-positioning of the phantom within the scanner led to errors in estimated phantom size of up to a factor of 1.5. These effects were more severe when localizers were acquired in the PA orientation compared with the AP orientation. Minification effects were more pronounced for AP localizers. As a consequence of inaccuracies in estimated phantom size, TCM resulted in changes in CTDI and SSDE of as much as a factor of 4.4 and 2.7, respectively. The effect was more pronounced when the TCM function used data from the PA, rather than the AP, localizer.
Proper patient positioning plays a large role in the function of TCM, and hence CTDI and SSDE. In addition, body mass distribution may affect how patients ought to be positioned within the scanner. Understanding these effects is critical in optimizing CT scanning practices.
作为CT方案常规评估的一部分,对剂量指标进行审查已变得很普遍,并且联合委员会和美国放射学会要求进行此项审查以获得认证。大多数CT质量保证计划都包括对CTDI和/或SSDE的审查,这两者都会受到mAs和kV变化的影响。mAs,有时还有kV,在很大程度上由扫描仪的管电流调制(TCM)功能决定。反过来,TCM依赖定位扫描来准确估计患者体型。当患者体型估计不准确时,TCM和SSDE计算都会受到影响,从而导致两者出现误差。参与审查CT剂量指标的人员必须认识到这些影响,以便正确指导质量改进措施。
使用前后位(AP)和后前位(PA)定位扫描以及该机构的常规腹部扫描方案,在四台临床CT扫描仪上对一个仿真人体模型进行扫描。在相对于扫描仪等中心的不同高度对模型重复进行扫描。对于每个高度,测量定位扫描显示的模型投影宽度,并通过螺旋扫描的宽度进行归一化。每次定位扫描后,TCM算法确定用于螺旋扫描的mAs。记录每次螺旋扫描时扫描仪报告的平均CTDI,并根据模型投影尺寸和每个模型高度处扫描仪报告的CTDI计算SSDE。最后,用脂质凝胶团块材料增大模型以模拟不同的体重分布,并研究不同体型对模型投影尺寸的影响。在优化CT成像剂量的背景下考虑这些结果,特别关注对乳腺组织剂量的影响。
模型在扫描仪内的垂直错位导致估计的模型尺寸误差高达1.5倍。与AP方向相比,当以PA方向获取定位扫描时,这些影响更严重。AP定位扫描的缩小效应更明显。由于估计的模型尺寸不准确,TCM导致CTDI和SSDE分别变化高达4.4倍和2.7倍。当TCM功能使用PA而非AP定位扫描的数据时,这种影响更明显。
正确的患者定位在TCM功能中起着很大作用,进而对CTDI和SSDE也有很大影响。此外,体重分布可能会影响患者在扫描仪内的定位方式。了解这些影响对于优化CT扫描实践至关重要。